India foresees spread of generics seizures via ACTA

The drug seizure agreement between India and the EU, intended to stop European customs officials from seizing legitimate generics on their way to Africa and Latin America by claiming patent infringement, may be for naught. And India may be facing the same issue on a larger scale in the likely soon-to-be enacted Anti-Counterfeiting Trade Agreement. ACTA still promotes an EU-style legal regime that would facilitate cross-border seizures of legitimate and lawful generic medicines that transit through any member country, says one law professor. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.